KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) EPS (Basic) (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed EPS (Basic) for 16 consecutive years, with $4.26 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, EPS (Basic) fell 4.05% year-over-year to $4.26, compared with a TTM value of $16.0 through Sep 2024, up 4.3%, and an annual FY2023 reading of $15.52, down 12.56% over the prior year.
  • EPS (Basic) was $4.26 for Q3 2024 at Thermo Fisher Scientific, up from $4.06 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $6.3 in Q4 2020 and bottomed at $1.99 in Q1 2020.
  • Average EPS (Basic) over 5 years is $4.25, with a median of $4.21 recorded in 2021.
  • The sharpest move saw EPS (Basic) surged 197.99% in 2021, then tumbled 40.99% in 2023.
  • Year by year, EPS (Basic) stood at $6.3 in 2020, then plummeted by 33.17% to $4.21 in 2021, then decreased by 4.28% to $4.03 in 2022, then grew by 4.47% to $4.21 in 2023, then rose by 1.19% to $4.26 in 2024.
  • Business Quant data shows EPS (Basic) for TMO at $4.26 in Q3 2024, $4.06 in Q2 2024, and $3.47 in Q1 2024.